tbuckley/cabot-search huggingface dataset:
The presence of <i>Aspergillus fumigatus</i> in asthmatic airways is not clearly related to clinical disease severity
Authors: Ashley Sullivan, Eoin B. Hunt, Chris Ward, Susan Lapthorne, Joseph A. Eustace, Liam J. Fanning, Barry J. Plant, Paul M. O'Byrne, John A. MacSharry, Desmond M. Murphy
Journal: Allergy (2019)

Abstract Background It is suggested that airway fungi, in particular Aspergillus may impinge on clinical phenotype in asthma. Indeed, the term severe asthma with fungal sensitization (SAFS) has been coined. We aimed to ascertain whether the presence of fungi, in particular Aspergillus fumigatus , in the airway correlated with asthma severity and control. Furthermore, we aimed to determine whether traditional markers of Aspergillus sensitization related to the presence of Aspergillus within the airway. Methods Sixty‐nine patients characterized by asthma severity (GINA) and level of control (ACQ‐7) underwent bronchoscopy and bronchoalveolar lavage (BAL). Serum was assessed for A fumigatus‐ specific IgE and total IgE. Galactomannan and relevant cytokine levels were assessed in serum, plasma and BAL. BAL was analyzed for the presence of A fumigatus. Results In BAL, fungi were visible by microscopy in 70% and present by qPCR in 86% of patients, while A fumigatus was detectable by qPCR in 46%. Plasma and BAL IL‐4, IL‐6, IL‐10, IL‐13 and TNF‐α correlated with BAL fungal presence, while plasma IL‐17 correlated with BAL fungal presence. Aspergillus positive BAL correlated with increased plasma and BAL IL‐6 and BAL IL‐13. There was no relationship between fungal airway presence and steroid dose, asthma severity or control. The presence of Aspergillus within the airway did not relate to serum IgE positivity for Aspergillus . Conclusions Fungi were present in a large proportion of our asthmatic patients’ airways, but their presence was not predicted by traditional markers of sensitization, nor did it appear to be related to measures of disease severity or control.
Cancer screening: from uptake to informed decision making
Authors: Fiona Godlee
Journal: BMJ (2019)

Colorectal cancer is the third most common cancer worldwide and the second most common cause of cancer related death. In developed countries one in 20 people will develop the disease. Given this major burden, establishing screening programmes has been a public health priority. People at average risk are generally offered screening once they reach 50, but there is no consensus on which tests to use or how often. The Rapid Recommendations team has now taken up this issue, asking whether screening makes an important difference to health outcomes, and …
An Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Backbone Regimens in Patients with Multiple Myeloma
Authors: Philippe Moreau, Maria-Victoria Mateos, Joan Bladé, Lotfi Benboubker, Javier de la Rubia, Thierry Facon, Raymond L. Comenzo, Joseph W. Fay, Xiang Qin, Tara Masterson, Jordan Schecter, Tahamtan Ahmadi, Jesus San Miguel
Journal: Blood (2014)
Randomized Controlled Trial Of Dalteparin For Primary Thromboprophylaxis For Venous Thromboembolism (VTE) In Patients With Advanced Pancreatic Cancer (APC): Risk Factors Predictive Of VTE
Authors: Saroj Vadhan-Raj, Xiao Zhou, Gauri R. Varadhachary, Javle Milind, David Fogelman, Rachna Shroff, Carlos E. Bueso-Ramos, Martin Nguyen, Xuemei Wang, Robert A. Wolff, James L. Abbruzzese, Michael J. Overman
Journal: Blood (2013)
Potential Targeting Ph+ Acute Lymphoblastic Leukemia Stem and Progenitor Cells By Modulating the CIP2A-SET-SETBP1 -Mediated Suppression of PP2A Activity
Authors: Justine Yu, Giovannino Silvestri, Lorenzo Stramucci, Masashi Sanada, Tomoyuki Yamaguchi, Yang Du, Jukka Westermarck, Michael A. Caligiuri, Ramiro Garzon, Dragana Milojkovic, Jane F. Apperley, Denis-Claude Roy, Guido Marcucci, Bruno Calabretta, Maria R. Baer, Rossana Trotta, Danilo Perrotti
Journal: Blood (2016)
Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.
Authors: Khaled M Ramadan, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Heather J. Sutherland, Julye Lavoie, Donna L. Forrest, Donna E. Hogge, Nicholas Voss, Ryan Brinkman, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze
Journal: Blood (2008)
Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000)
Authors: Martin Schrappe, Martin Zimmermann, Anja Möricke, Georg Mann, Maria Grazia Valsecchi, Claus R Bartram, Andrea Biondi, Renate Panzer-Grümayer, André Schrauder, Franco Locatelli, Alfred Reiter, Giuseppe Basso, Felix Niggli, Maurizio Aricò, Valentino Conter
Journal: Blood (2008)
Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients.
Authors: Antonio Palumbo, Sara Bringhen, Davide Rossi, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Anna Levi, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Barbara Olivero, Fortunato Morabito, Mariella Grasso, Roberto Marasca, Manuela Rizzo, Antonietta Pia Falcone, Daniela Gottardi, Vittorio Montefusco, Caterina Musolino, Renato Zambello, Clotilde Cangialosi, Giuseppe Pietrantuono, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Giovannino Ciccone, Francesco Di Raimondo, Gianluca Gaidano, Mario Boccadoro
Journal: Blood (2009)
The Impact of Regional Cardiovascular Care Outcomes on Survival and Cardiovascular-Specific Mortality in Myelodysplastic Syndrome
Authors: Andrew M. Brunner, Traci M. Blonquist, Gabriela Soriano Hobbs, Philip C. Amrein, Hanno Hock, Karen K. Ballen, Donna S. Neuberg, Amir T. Fathi
Journal: Blood (2016)
Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study
Authors: Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola, Mohsen Elalfy, Amal El-Beshlawy, Madatha V. Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramabadran Varadarajan, Mehran Karimi, Mamta V. Manglani, Cecil Ross, Guy Young, Tulika Seth, Shashikant Apte, Dinesh M. Nayak, Adriana C. Sandoval Gonzales, Elena Santagostino, Maria Elisa Mancuso, Johnny N. Mahlangu, Santiago Bonanad, Monica Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, Veronica Soto Arellano, Nathan L. Kobrinsky, Suvankar Majumdar, Rosario Perez Garrido, Anupam Sachdeva, Mindy Simpson, Mathew Thomas, Ezio Zanon, ALI Bulent Antmen, Kaan Kavakli, Marilyn Manco-Johnson, Monica Martinez, Esperanza Marzouka, Maria Gabriella Mazzucconi, Daniela Neme, Angeles Palomo Bravo, Rogelio Paredes Aguilera, Alessandra Nunes Loureiro Prezotti, Schmitt Klaus, Brian M. Wicklund, Bulent Zulfikar, Rosendaal R. Frits
Journal: Blood (2015)
FTY720 (2-Amino-2-[2-(4-octylphenyl) ethyl] Propane 1, 3-diol hydrochloride), Mediates Cytotoxicity through Caspase Independent and Protein Phosphatase 2A Dependent Mechanisms in Chronic Lymphocytic Leukemia and Lymphoblastic Leukemia/Lymphoma.
Authors: Qing Liu, Xiaobin Zhao, Frank Frissora, Yihui Ma, Ramasamy Santhanam, Danilo Perrotti, Ching-Shih Chen, James T. Dalton, John C. Byrd, Natarajan Muthusamy
Journal: Blood (2006)
OPEC/Mpec for Adult T-Cell Leukemia/Lymphoma: A Single-Institution Study
Authors: Daisuke Nakamura, Makoto Yoshimitsu, Tomohisa Tabuchi, Naosuke Arima, Maiko Hayashida, Hirosaka Inoue, Kakushi Matsushita, Tadashi Matsumoto, Naomichi Arima, Kenji Ishitsuka
Journal: Blood (2016)
Engraftment and Long-Term Survival at Low Burden of Leukemic Blasts from Primary MRD+ Human Bone Marrow in a Xenotransplant Setting
Authors: Nina Rolf, Angela Tsang, Abbas Fotovati, Arnawaz Bashir, Patrice Eydoux, Suzanne M Vercauteren, Gregor SD Reid
Journal: Blood (2016)
Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing
Authors: Niels W.C.J. van de Donk, Henk M. Lokhorst, Maarten Emmelot, Tineke Aarts-Riemens, Douglas W. McMillin, Gullu Gorgun, Steffen Klippel, Eugen Dhimolea, Jana Jakubikova, Catriona A. Hayes, Panisinee Lawasut, Jake E Delmore, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson, Constantine S. Mitsiades, Tuna Mutis
Journal: Blood (2011)
Impact of cytogenetic abnormalities on response to azacitidine in patients with myelodysplastic syndrome
Authors: Hiroko Iizuka, Keiji Sugimoto, Haruko Takizawa, Mutsumi Wakabayashi, Sakura Sakajiri, Yasunobu Sekiguchi, Masaaki Noguchi, Norio Komatsu
Journal: Annals of Oncology (2019)
Outcome of Adolescents and Young Adults (AYAs) with Non-M3 Acute Myeloid Leukemia (AML) Treated on Children's Oncology Group (COG) Trials Compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) Trials
Authors: Anna R.K. Franklin, Todd A. Alonzo, Robert B. Gerbing, Kathleen Donohue, Megan Othus, John Horan, Elihu H. Estey, Richard A. Larson, William G. Woods
Journal: Blood (2010)
The Zebrafish Hypochromic Mutant [iItalic]Shiraz[/iItalic] Encodes a Novel Mitochondrial Glutaredoxin That Establishes a Link between Heme and Fe/S Production.
Authors: Rebecca A. Wingert, Bruce Barut, Helen Foott, Paula Fraenkel, Kimberly Dooley, Paul Kingsley, Jim Palis, Heidi Shubert, Opal Chen, Jerry Kaplan, Leonard I. Zon
Journal: Blood (2004)
ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83+ Dendritic Cells.
Authors: Naoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, Takeshi Hagino, Satoshi Noto, Akiyoshi Miwa
Journal: Blood (2012)
Phase I Study of Triciribine Phosphate Monohydrate, a Specific Inhibitor of AKt Phosphorylation, in Adult Patients with Advanced Hematologic Malignancies.
Authors: Farhad Ravandi, Jeffrey Lancet, Francis Giles, William Plunkett, Betsy Williams, Michelle Burton, Stefan Faderl, Zeev Estrov, Gautam Borthakur, Lawrence Akinsanmi, Hagop Kantarjian
Journal: Blood (2007)
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Authors: Erik J.M. van Bommel, Marcel H.A. Muskiet, Michaël J.B. van Baar, Lennart Tonneijck, Mark M. Smits, Anna L. Emanuel, Andrea Bozovic, A.H. Jan Danser, Frank Geurts, Ewout J. Hoorn, Daan J. Touw, Emil L. Larsen, Henrik E. Poulsen, Mark H.H. Kramer, Max Nieuwdorp, Jaap A. Joles, Daniël H. van Raalte
Journal: Kidney International (2019)
Exploratory Analysis of Nivolumab Effectiveness with Lab Data in NSCLC pts in Japan: A Multicenter-Retrospective Study
Authors: Keisuke Aoe, Ryo Morita, Kyoichi Okishio, Junichi Shimizu, Haruhiro Saito, Hiroshi Sakai, Yong Hak Kim, Osamu Hataji, Makiko Yomota, Makoto Nishio, Osamu Kanai, Toru Kumagai, Kayoko Kibata, Hiroaki Tsukamoto, Satoshi Oizumi, Keisuke Tomii, Hiroshi Tanaka, Keiko Mizuno, Hirotoshi Hoshiyama, Kenya Ochi, Yuichiro Ohe
Journal: Annals of Oncology (2019)
Results of a Phase 1/2 Study for KW-0761, a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4), In CTCL Patients
Authors: Madeleine Duvic, Lauren Pinter-Brown, Francine M Foss, Lubomir Sokol, Jeffrey Jorgensen, George L Spitalny, Youn H. Kim
Journal: Blood (2010)
Allogeneic Stem Cell Transplantation Can Be an Effective Post-Remission Strategy for Acute Myeloid Leukemia Patients Aged Less Than 60 Years with Core Binding Factor: A Nation-Wide Retrospective Study in Korea.
Authors: Ho-Jin Shin, Joo Seop Chung, Hyioung-Joon Kim, Sang Kyun Sohn, Yoo Hong Min, Jong-Ho Won, Inho Kim, Je-Hwan Lee, Jae Hoon Lee, Chul Won Jung, Jin Seok Ahn, Kyoo-Hyung Lee, Young Don Joo
Journal: Blood (2007)
Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML
Authors: Brian C. Shaffer, Glenn Heller, Jean-Benoit Le Luduec, Jack Vahradian, Miguel Perales, Sergio A. Giralt, Roni Tamari, Boglarka Gyurkocza, Ann A. Jakubowski, E B Papadopoulos, Jeanette E Boudreau, Nancy A. Kernan, Katharine C. Hsu
Journal: Blood (2016)
Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers
Authors: Mauricio Sarmiento, Rocio Parody, Queralt Salas, Nicole Beffermann, Veronica Jara, Pablo A Bertin, Isabel Sánchez-Ortega, Pablo Ramirez, Mauricio Ocqueteau, Beatriz Patiño, Anna Sureda
Journal: Blood (2016)
Phase I Study of KW-0761, a Humanized Anti-CCR4 Antibody, in Patients (Pts) with Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATLL) and Peripheral T-Cell Lymphoma (PTCL): Preliminary Results.
Authors: Naokuni Uike, Kunihiro Tsukasaki, Atae Utsunomiya, Kensei Tobinai, Yasuo Morishima, Kimiharu Uozumi, Masao Tomonaga, Koji Matsushima, Knya Shitara, Shiro Akinaga, Ryuzo Ueda
Journal: Blood (2007)
High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.
Authors: Philip Bierman, Hina Naushad, Fausto Loberiza, R. Gregory Bociek, Julie M. Vose, James Olen Armitage, Patricia Aoun
Journal: Blood (2006)
Using BH3 Profiling As a Predictive Indicator for Myeloma Patient Response to Bortezomib,
Authors: Michael Thomenius, Jan Cerny, Ryan Lena, Triona Chonghaile, Stephanie Walters, Stephen Lyle, Rajneesh Nath, Ramanthan Muthalagu, Krumpe Lindsey, Anthony G. Letai, Michael Cardone
Journal: Blood (2011)
Avelumab in platinum-resistant/refractory ovarian cancer (PRROC): phase 3 results from JAVELIN Ovarian 200
Authors: Kan Yonemori, Takashi Matsumoto, Shoji Nagao, Noriyuki Katsumata, Katsutoshi Oda, Hidemichi Watari, Hideki Tokunaga, Hiroyuki Fujiwara, Harushige Yokota, Takeshi Hirasawa, Toshiaki Nakamura, Mana Aizawa, Tomoko Okubo, Keiichi Fujiwara
Journal: Annals of Oncology (2019)
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Authors: Yang Shi, Melissa Manis, Justin Long, Kairuo Wang, Patrick M. Sullivan, Javier Remolina Serrano, Rosa Hoyle, David M. Holtzman
Journal: The Journal of Experimental Medicine (2019)

Chronic activation of brain innate immunity is a prominent feature of Alzheimer's disease (AD) and primary tauopathies. However, to what degree innate immunity contributes to neurodegeneration as compared with pathological protein-induced neurotoxicity, and the requirement of a particular glial cell type in neurodegeneration, are still unclear. Here we demonstrate that microglia-mediated damage, rather than pathological tau-induced direct neurotoxicity, is the leading force driving neurodegeneration in a tauopathy mouse model. Importantly, the progression of ptau pathology is also driven by microglia. In addition, we found that APOE, the strongest genetic risk factor for AD, regulates neurodegeneration predominantly by modulating microglial activation, although a minor role of apoE in regulating ptau and insoluble tau formation independent of its immunomodulatory function was also identified. Our results suggest that therapeutic strategies targeting microglia may represent an effective approach to prevent disease progression in the setting of tauopathy.
Evaluation of Salvage Induction Chemotherapy Regimens in Higher Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia after Hypomethylating Agent Treatment Failure
Authors: Brian Ball, Rami S. Komrokji, Lionel Ades, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven Gore, Pierre Fenaux, Thomas Prebet
Journal: Blood (2016)
Presence of PD-1 Expressing T Cells Predicts for Inferior Overall Survival in Newly Diagnosed Multiple Myeloma
Authors: Gasmi Billel, Eric L Smith, Ahmet Dogan, Meier Hsu, Sean Devlin, Janine D. Pichardo, David J Chung, Guenther Koehne, Neha S Korde, Heather J Landau, Sergio A. Giralt, Ola Landgren, Hani Hassoun, Alexander M. Lesokhin
Journal: Blood (2015)
A Direct Comparison of High Dose Cytarabine to Combination of Gemtuzumab and High Dose Cytarabine for Acute Myeloid Leukemia Patients in First Relapse Confirmed the Benefit of Gemtuzumab Based Regimens.
Authors: Thomas Prébet, Aude Charbonnier, Anne Etienne, Evelyne D'Incan, Sabine Fürst, Didier Blaise, Norbert Vey
Journal: Blood (2009)
Multidrug-Resistant Salmonella
Authors: Bridget Kuehn
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Enhanced Phosphorylation of Nbs1, a Member of DNA Repair/Checkpoint Complex RAD50-Mre11-Nbs1, Can Be Targeted Simultaneously with BCR/ABL Kinase To Eliminate Leukemia Cells.
Authors: Lori Rink, Tomasz Stoklosa, Margaret Nieborowska-Skorska, Artur Slupianek, Ilona Seferynska, Tomasz Skorski
Journal: Blood (2006)
Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis
Authors: Suzanne Lentzsch, Raymond L. Comenzo, Keren Osman, Kevin Zikaras, Daniel Backenroth, Wei-Yann Tsai, Vaishali Sanchorawala, Heather Landau
Journal: Blood (2014)
Faster Engraftment and Immune Reconstitution after Haploidentical Allogenic Hematopoietic Cell Transplantation with CD3/CD19 Depleted as Compared to CD34 Selected Grafts.
Authors: Haegele Matthias, Christoph Faul, Peter Lang, Michael Schumm, Rupert Handgretinger, Lothar Kanz, Wolfgang A. Bethge
Journal: Blood (2005)
Outcomes of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Surviving More Than 5 Years (yrs) after Initial Therapy with TKIs
Authors: Eran Tallis, Hagop M. Kantarjian, Catherine Kendall Major, Maria Vazquez, Gautam Borthakur, Prithviraj Bose, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, William G. Wierda, Alessandra Ferrajoli, Naveen Pemmaraju, Naval G. Daver, Courtney D. DiNardo, Marina Y. Konopleva, Steven M. Kornblau, Richard E Champlin, Elias J. Jabbour, Sherry A. Pierce, Jorge E. Cortes
Journal: Blood (2018)
Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Preparative Regimen for Adult Patients with Acute Lymphoblastic Leukemia in CR: A Survey from the European Group for Blood and Marrow Transplantation (EBMT).
Authors: Nadezda Basara, Myriam Labopin, Tapani Ruutu, Axel Zander, Renate Arnold, Vanderson Rocha
Journal: Blood (2006)
Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia
Authors: Steven Peter Treon, Christina K Tripsas, Kirsten Meid, Christopher Patterson, Leonard T Heffner, Herbert Eradat, Stephanie A. Gregory, Sheeba K. Thomas, Ranjana H. Advani, Rachid Baz, Ashraf Z. Badros, Jeffrey Matous, Timothy J. Murphy, Irene M. Ghobrial
Journal: Blood (2013)
MiR-146a Regulates the TRAF6/TNF-Axis in Donor T Cells during Graft-Versus-Host Disease
Authors: Natalie Stickel, Gabriele Prinz, Dietmar Pfeifer, Annette Schmitt-Graeff, Marie Follo, Jürgen Finke, Justus Duyster, Ulrich Salzer, Robert Zeiser
Journal: Blood (2014)
Chimeric T Cells for Therapy of CD30+ Hodgkin and Non-Hodgkin Lymphomas
Authors: Carlos A. Ramos, Brandon Ballard, Enli Liu, Olga Dakhova, Zhuyong Mei, Hao Liu, Bambi Grilley, Cliona M. Rooney, Adrian P. Gee, Bill H. Chang, Catherine M. Bollard, Malcolm K. Brenner, Gianpietro Dotti, Helen E. Heslop, Barbara Savoldo
Journal: Blood (2015)
Pharmacological Profile of DZ-697b, a Novel Anti-Platelet Agent -Selective Inhibitor of vWF- and Collagen-Induced Platelet Aggregation.
Authors: Yoshiyasu Ogihara, Sumie Muramatsu, Yuki Kaneda, Takako Iijima, Tomoko Shibutani, Toshiro Shibano
Journal: Blood (2005)
Disrupted Expression of the Splicing Regulators Tra2-Beta and SRSF1 and Subsequent Aberrant Splicing of FLVCR1 Transcript As an Underlying Mechanism for the Erythropoietic Failure Observed in Diamond-Blackfan Anemia
Authors: Chetankumar S Tailor, Francisco Ama Aidoo, Abigail Brenda Fernandes, Rutvikkumar Patel, Yigal Dror
Journal: Blood (2015)
SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis
Authors: Arghya Ray, Deepika Sharma Das, Durgadevi Ravillah, Yan Song, Vincent Macri, Christopher Brooks, Eric Rowinsky, Paul G. Richardson, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood (2014)
Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant
Authors: Lisi Huang, Xin Du, Jianyu Weng, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, Chengwei Luo, Xin Huang, Suxia Geng
Journal: Blood (2015)
A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).
Authors: David P Steensma, Shaker R. Dakhil, Robert Dalton, Stephen P Kahanic, John W Kugler, Philip J Stella, Kendrith M Rowland, Paul J Novotny, Jeff A Sloan, Charles L Loprinzi
Journal: Blood (2009)
Interferon Alpha 2a (IFN) Maintenance Therapy After Imatinib Plus IFN Induction Therapy in Chronic Myeloid Leukemia (CML) Induces Stable Long-Term Molecular Remissions and Is Associated with Increased Proteinase 3 (PR3) Expression and the Presence of PR1-Specific T-Cells.
Authors: Andreas Burchert, Martin C Müller, Philippe Kostrewa, Philipp Erben, Tilman Bostel, Simone Liebler, Rüdiger Hehlmann, Andreas Neubauer, Andreas Hochhaus
Journal: Blood (2009)
A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results
Authors: Lisa Pieri, Chiara Paoli, Paola Guglielmelli, Rajmonda Fjerza, Umberto Arena, Fabio Marra, Stefano Colagrande, Fabio Mori, Roberto Marchioli, Raffaella Pioggiarella, Marco Ruggeri, Ilaria Nichele, Guido Finazzi, Maria Luisa Ferrari, Vittorio Rosti, Valerio De Stefano, Elisa Rumi, Carmela Mannarelli, Tiziana Fanelli, Alberto Bosi, Alessandro Rambaldi, Giovanni Barosi, Mario Cazzola, Tiziano Barbui, Alessandro M Vannucchi
Journal: Blood (2013)
Inhibition of MEK and DDR Pathways Induces Synergistic Killing of Novel Mll-Af4 B-ALL Model Harboring Activated Ras Mutations
Authors: Evelyn J Song, S. Haihua Chu, Janna Minehart, Jonathan Chabon, Richard Koche, Andrei Krivtsov, Scott A. Armstrong
Journal: Blood (2016)
CD20 Protein Immunohistochemistry-Positive/Flow Cytometry-Negative Diffuse Large B-Cell Lymphoma—Analyses of the Molecular Mechanisms and Rituximab Effectiveness
Authors: Takashi Tokunaga, Akihiro Tomita, Junji Hiraga, Takumi Sugimoto, Kazuyuki Shimada, Keiki Sugimoto, Tomohiro Kinoshita, Tomoki Naoe
Journal: Blood (2011)